Cargando…
Novel therapeutic strategies for advanced ovarian cancer by using induced pluripotent stem cell‐derived myelomonocytic cells producing interferon beta
Although first‐line chemotherapy has a high rate of complete responses in ovarian cancer patients, the vast majority of patients present with recurrent disease that has become refractory to conventional chemotherapy. Peritoneal dissemination and malignant ascites are the hallmarks of recurrent or ad...
Autores principales: | Imamura, Yuko, Tashiro, Hironori, Tsend‐Ayush, Gandolgor, Haruta, Miwa, Dashdemberel, Narantuya, Komohara, Yoshihiro, Tsuboki, Junko, Takaishi, Kiyomi, Ohba, Takashi, Nishimura, Yasuharu, Katabuchi, Hidetaka, Senju, Satoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215869/ https://www.ncbi.nlm.nih.gov/pubmed/30142694 http://dx.doi.org/10.1111/cas.13775 |
Ejemplares similares
-
Choriocarcinoma coexisting with epithelioid trophoblastic tumor of the uterine horn
por: Imamura, Yuko, et al.
Publicado: (2015) -
Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages
por: Tsuboki, Junko, et al.
Publicado: (2016) -
CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
por: Tjhay, Francisca, et al.
Publicado: (2015) -
The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer
por: Tayama, Shingo, et al.
Publicado: (2017) -
Corosolic acid enhances the antitumor effects of chemotherapy on epithelial ovarian cancer by inhibiting signal transducer and activator of transcription 3 signaling
por: FUJIWARA, YUKIO, et al.
Publicado: (2013)